Join the Leukemia group to help and get support from people like you.
Leukemia News
Related terms: Cancer, Leukemia
Ophthalmologic Manifestations of Acute Leukemia Are Heterogeneous
WEDNESDAY, July 17, 2024 – Ophthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a study published online July 10 in the...
Safe Pregnancies Possible After Stem Cell Treatment for Blood Cancer
TUESDAY, July 16, 2024 – Women who've undergone stem cell treatments for blood cancers, or for illnesses such as sickle cell disease, can successfully bring a pregnancy to term, new research shows....
Posttransplant Cyclophosphamide GVHD Prophylaxis Beneficial in Leukemia
MONDAY, June 24, 2024 – For patients with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplantation, posttransplant cyclophosphamide (PTCy) graft-versus-host-disease (GVHD)...
Trametinib Safe, Effective for Juvenile Myelomonocytic Leukemia
TUESDAY, June 18, 2024 – For children with relapsed or refractory juvenile myelomonocytic leukemia (JMML), trametinib is safe and effective, according to a study published online June 12 in Cancer...
Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy
FRIDAY, June 14, 2024 – Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England Journal of...
Secondary Tumors After CAR-T Cancer Therapies Are Rare: Study
THURSDAY, June 13, 2024 – CAR-T cell therapy to treat blood cancers is safer than previously thought, with little risk that the immunotherapy will create secondary cancers, a new study finds. The...
ASCO: Asciminib Has Superior Efficacy to TKIs for Newly Diagnosed Leukemia
WEDNESDAY, June 5, 2024 – For patients with newly diagnosed chronic myeloid leukemia (CML), asciminib shows superior efficacy and a favorable safety profile compared with investigator-selected...
Strategy with Cyclophosphamide Could Expand Stem Cell Donor Pool for People Battling Blood Cancers
TUESDAY, May 28, 2024 – An older drug used in a new way could open the path for more patients with potentially deadly blood cancers to receive a lifesaving stem cell transplant, a new study finds....
Lower Prevalence of Employment Seen for Survivors of Childhood Cancer
FRIDAY, May 10, 2024 – Adult survivors of childhood cancer have declines in employment and increases in health-related unemployment compared with the general population, according to a study...
CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumors
THURSDAY, April 25, 2024 – For patients with relapsed or refractory CD7-positive leukemia or lymphoma, sequential CD7 chimeric antigen receptor (CAR) T-cell therapy followed by haploidentical...
Longer Exclusive Breastfeeding May Lower Risk for Childhood Hematologic Cancers
THURSDAY, March 28, 2024 – Exclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study published online March 26 in JAMA ...
Survival 21 Percent a Year After ICU Discharge for Blood Cancer Patients
THURSDAY, March 21, 2024 – For hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study...
Odds of Severe COVID-19 High for Hematologic Cancer Patients During Pandemic
THURSDAY, Feb. 29, 2024 – For patients with hematologic cancers, the odds of developing severe COVID-19 despite vaccination remained high through mid-2022, according to a study published online Feb....
Outcomes Similar for Therapy-Related, De Novo MDS After Haplo-HSCT
WEDNESDAY, Feb. 21, 2024 – Patients with therapy-related myelodysplastic syndrome (t-MDS) and de novo MDS have comparable outcomes after haploidentical hematopoietic stem cell transplantation...
FDA Warns of Rare Secondary Cancer Risk With CAR-T Therapies
WEDNESDAY, Jan. 24, 2024 (Healthday News) – The U.S. Food and Drug Administration has told drugmakers to add a boxed warning to a type of cancer treatment called CAR-T therapy, saying the treatment...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Myelogenous Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hairy Cell Leukemia, Blood Disorders